CD122 / IL2RB, C-His, recombinant protein from ProteoGenix; catalogue PX-P5555; research use only.
Know who made it. See the evidence. Buy through one marketplace.
CD122, also known as Interleukin-2 Receptor Beta (IL2RB), is a type I transmembrane glycoprotein that belongs to the cytokine receptor superfamily. It is composed of an extracellular domain, a transmembrane domain, and an intracellular domain. The extracellular domain is composed of three immunoglobulin-like domains, while the intracellular domain consists of two tyrosine-based activation motifs.
CD122/IL2RB ActivityCD122 is a receptor for Interleukin-2 (IL-2), a cytokine that plays an important role in the regulation of the immune response. The binding of IL-2 to CD122 triggers a series of intracellular signaling pathways, leading to the activation of various downstream molecules such as Janus kinases (JAKs) and signal transducers and activators of transcription (STATs).
CD122/IL2RB ApplicationCD122 plays an important role in the regulation of the immune response, and its expression has been associated with various immune disorders, such as autoimmune diseases, allergies, and cancer. In addition, CD122 has been studied as a potential target for therapeutic intervention in these diseases.
ProteoGenix catalogue number PX-P5555. For research use only.
Host: Mammalian cells; Expression system: Eukaryotic expression; Purity: >90% as determined by SDS-PAGE; Molecular weight: 28.32 kDa; Tag: C-terminal His Tag; Fragment: Met1-Asp239; Buffer: PBS, pH7.5; Applications: ELISA, WB.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
